Asymptomatic and Recurrent Hyperparathyroidism

por Farndon, J R
Publicado 1989

What's New from the British Journal of Surgery

por Farndon, J. R.
Publicado 1992

Editorial Board of the West of England Medical Journal AGM

por Goddard, P., Farndon, J. R.
Publicado 1992

Epidermal Growth Factor Receptors and Breast Cancer

por Farndon, J. R., Nicholson, S., Sainsbury, J. R. C., Harris, A. L.
Publicado 1989

Binding of urokinase to specific receptor sites on human breast cancer membranes.

por Needham, G. K., Sherbet, G. V., Farndon, J. R., Harris, A. L.
Publicado 1987

Measurement of oestrogen receptor mRNA levels in human breast tumours.

por Henry, J. A., Nicholson, S., Farndon, J. R., Westley, B. R., May, F. E.
Publicado 1988

Four Hunterian Lectures and Bristol–1990

por Clarke, N. M. P., Miller, R., Nicholson, S., Scott, D. J. A., Farndon, J. R.
Publicado 1991

Epidermal growth factor receptor status of histological sub-types of breast cancer.

por Sainsbury, J. R., Nicholson, S., Angus, B., Farndon, J. R., Malcolm, A. J., Harris, A. L.
Publicado 1988

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.

por Nicholson, S., Halcrow, P., Sainsbury, J. R., Angus, B., Chambers, P., Farndon, J. R., Harris, A. L.
Publicado 1988

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.

por Henry, J. A., Piggott, N. H., Mallick, U. K., Nicholson, S., Farndon, J. R., Westley, B. R., May, F. E.
Publicado 1991

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

por Nicholson, S., Richard, J., Sainsbury, C., Halcrow, P., Kelly, P., Angus, B., Wright, C., Henry, J., Farndon, J. R., Harris, A. L.
Publicado 1991